Literature DB >> 23856815

Acute changes in central corneal thickness according to experimental adjustment of intraocular pressure in normal canine eyes.

Young-Woo Park1, Man-Bok Jeong, Eui Ri Lee, Yesran Lee, Jae-Sang Ahn, Soo-Hyun Kim, Kangmoon Seo.   

Abstract

Central corneal thickness (CCT) can be a promising source of glaucoma monitoring and diagnosis. This study evaluated changes in CCT according to experimental adjustment of intraocular pressure (IOP) in canine eyes. To adjust and measure IOP, each eye was cannulated with two 26-gauge needles under inhalant anesthesia. One needle was connected to a pressure transducer, and the other was connected to an adjustable bag of physiologic saline. IOP was stepwise increased from 10 mmHg to 70 mmHg in 10 mmHg increments (Group T). IOP was maintained at 15 mmHg (Group C15), 30 mmHg (Group C30), 45 mmHg (Group C45), 60 mmHg (Group C60) and 75 mmHg (Group C75) during the experiment. CCT was measured with an ultrasonic pachymeter every 10 min after cannulation. There was a significant difference in the effect of time on CCT (P<0.001) and difference in CCT (dCCT; P<0.001) between groups. The CCT of group C15 remained constant during the experiment. However, group T showed an initial decrease and then an increase after passing the lowest point. Group C30 showed decreasing values for 30 min, after which the values remained constant. The values in Group C45 showed no changes for 40 min and then increased. The values in group C60 showed no change for 20 min and then increased. Group C75 showed a steady increase. In conclusion, the CCT showed two core changes according to increased IOP. This study provides essential basic data to enable further investigation into the association of IOP and CCT in dogs.

Entities:  

Mesh:

Year:  2013        PMID: 23856815      PMCID: PMC3942985          DOI: 10.1292/jvms.13-0174

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


The canine cornea consists of 5 layers: The epithelium, basement membrane, stroma, Descemet’s membrane and endothelium [21]. The normal thickness of the canine cornea is approximately 550 microns in the central area, but the peripheral cornea is slightly thicker [7]. Both the epithelium and endothelium control corneal hydration, but the endothelium plays a more important role in this task [20]. The pump-leak hypothesis is considered the basic model of corneal hydration control. The cornea consists of two sets of receptors. One senses hydration, and the other modulates the activity of the endothelial pump. In addition, a linking system is needed to connect these two receptors [5]. Because the corneal endothelium is in direct contact with the aqueous humor, corneal thickness can be altered by conditions affecting the aqueous humor. Inflammation of the aqueous humor inhibits the function of the endothelial pump, leading to corneal edema [14]. Intraocular pressure (IOP) is formed by the production and drainage of aqueous humor, and changes in IOP can also affect corneal thickness [24, 25]. Two possible mechanisms of change in central corneal thickness (CCT) according to IOP can be considered. One is associated with the pump function of the corneal endothelium, which can be impaired when the IOP reaches the critical pressure. The other mechanism is the direct affect of elevated IOP on the mechanical properties of the cornea [24]. The ultrasonic pachymeter has disadvantages, such as false results due to indentation during measurement, the risk of infection by direct contact and inaccuracy due to the perpendicularity of the probe placement [11, 22]. However, the ultrasonic pachymeter is the gold standard for CCT measurement, because it has a noninvasive, simple method and high degree of interobserver reproducibility in humans [17]. Since the introduction of the ultrasonic pachymeter, CCT has been investigated in human glaucoma patients. Although this issue remains controversial, patients with a thin CCT have shown a high risk for glaucoma [8]. The current study was designed to investigate CCT acute response to the experimental adjustment of IOP in dogs. In addition, the possibility of CCT as a factor for diagnosis and monitoring of canine glaucoma was investigated.

MATERIALS AND METHODS

Animals studies and preparations: All animal procedures were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee of Seoul National University (SNU-111115-4). Both eyes of 25 clinically normal laboratory beagle dogs were used in this study. Complete ophthalmic examinations were performed before the experiment using a rebound tonometer (TonoVet, Tiolat, Helsinki, Finland), Schirmer Tear Test (Schirmer Tear Test, Schering-Plough Animal Health, Kenilworth, NJ, U.S.A.), slit-lamp biomicroscope (Topcon SL-D7, Topcon Corp., Tokyo, Japan) and indirect ophthalmoscope (Vantage, Keeler Instruments Inc., Broomall, PA, U.S.A.) with a 30-diopter indirect lens (Classic BIO Lens, Volk Optical Inc., Mentor, OH, U.S.A.). To investigate changes in CCT according to stepwise increases in IOP compared with a fixed normal IOP, 30 eyes of 15 dogs were used. The remaining eyes were used to investigate changes in CCT according to a fixed increase in IOP (30, 45, 60 and 75 mmHg). Before induction of anesthesia, atropine eye drops (Ocutropine, Samil, Gyeonggi, South Korea), a combination of phenylephrine and tropicamide eye drops (Mydrin-P, Saten Pharmaceutical, Osaka, Japan), a combination of dexamethasone, polymyxin B and neomycin eye drops (Maxitrol, S.A. Alcon-Couvreur N.V., Puurs, Belgium) and flurbiprofen eye drops (OcufenTM, Allergan Sales LLC, Waco, TX, U.S.A.) were all applied twice to achieve mydriasis and reduce inflammation induced by anterior chamber paracentesis. Acepromazine 0.03 mg/kg (Sedaject, Samwoo Medical, Chungnam, South Korea), cefazoline 30 mg/kg (CKD Cefazolin Inj., Chong Kun Dang, Gyeonggi, South Korea) and dexamethasone 0.3 mg/kg (Je Il Dexamethasone Inj., Je Il Pharmaceutical, Daegu, South Korea) were administered intravenously 5 min before anesthesia induction using propofol (ProviveTM 1%, Claris Lifesciences, Ahmedabad, India). Anesthesia was maintained with isoflurane (Ifran, Hana Pharm. Co., Ltd., Gyeonggi, South Korea) and oxygen. During anesthesia, ECG, pulse oxymetry, noninvasive blood pressure, end tidal CO2, capnography and temperature (with a digital thermometer) were monitored. After induction of anesthesia, the dog was laid in a dorsoventral position during the experiment. To induce extraocular muscle akinesia and prevent pain, retrobulbar injection of 2 ml of 2% lidocaine (Je Il lidocaine injection (2%), Je Il Pharmaceutical) was performed with a 23-gauge retrobulbar needle in each eye using the inferior-temporal palpebral technique [1]. In cases with inadequate extraocular muscle akinesia, a second injection of 1 ml of 2% lidocaine was performed 10 min after the first injection. An eye speculum was placed to expose the cornea after induction of extraocular muscle akinesia. The exposed cornea was frequently lubricated with 0.5% sodium carboxymethyl cellulose (Refresh PlusTM, Allergan Sales LLC) to prevent corneal desiccation during the experiment. The anterior chamber was entered with two 26-gauge needles through the limbus (2 and 10 o’clock positions) for each eye. Cyanoacrylate glue (3M VetbondTM, 3M Animal Care Products, St. Paul, MN, U.S.A.) was used to prevent leakage from the entry site after needle insertion. One needle was connected to a normal saline reservoir containing 5 IU per milliliter of heparin through a polypropylene line. The IOP was adjusted to different levels by changing the reservoir. The other needle was connected to a pressure transducer system for IOP measurement through a polypropylene line and contained normal saline with 5 IU per milliliter of heparin. The system comprised a pressure monitoring kit (Transpac IV Monitoring Kit, ICU Medical, Inc., San Clemente, CA, U.S.A.) with a transducer, polyethylene tubes, monitoring cable (Transpac Reusable Cable, Hospira, Inc., Lake Forest, IL, U.S.A.) and a monitor (Datex-Ohmeda S/5, Helsinki, Finland) for continuous monitoring of IOP (Fig. 1). The transducer was positioned at eye level. Before each experiment, the transducer was calibrated to a mercury manometer, and a zero balance was set using the manufacturer’s instructions.
Fig. 1.

Schematic of the experiment after cannulation in an eye.

Schematic of the experiment after cannulation in an eye. Procedures for stepwise increase of IOP and fixed normal IOP: Thirty eyes of 15 dogs were randomly assigned to groups T and C15. In group T, the IOP of 1 eye per dog was adjusted to 10 mmHg immediately after cannulation and was then raised in increments of 10 mmHg until a maximum IOP of 70 mmHg. CCT was measured with an ultrasonic pachymeter (Pachmate DGH 55, DGH Technology, Exton, PA, U.S.A.) 3 times at each IOP after each IOP maintenance for 10 min. The IOP in the other eye was adjusted to 15 mmHg (group C15) immediately after cannulation, which was maintained throughout the experiment. An ultrasonic pachymeter was also applied every 10 min in the same manner as for group T. Procedures for fixed increase of IOP: Twenty eyes of 10 dogs were randomly assigned to groups C30, C45, C60 and C75. Each group consisted of 5 eyes from different dogs. The IOP was respectively adjusted to 30, 45, 60 and 75 mmHg in these groups immediately after cannulation and was maintained throughout the experiment. An ultrasonic pachymeter was also applied every 10 min in the same manner as for groups T and C15. Post-experimental care: Triamcinolone 4 mg/kg (Rheudenolone Inj., Kukje Pharma. Ind., Gyeonggi, South Korea) and gentamicin 8 mg/kg (Kukje Gentamicin Inj., Kukje Pharma. Ind.) were injected into the subconjunctiva to reduce inflammation and infection after the experiment. A combination eye drop comprising dexamethasone, polymyxin B and neomycin was then applied 2 times per day for 1 week. Statistical analysis: Statistical analysis was performed using PASW Statistics 18 for Windows (SPSS Inc., Chicago, IL, U.S.A.). CCT data were expressed as the mean ± SE (standard error), and the level of significance used was P<0.05. In one-way repeated measures ANOVA following pairwise comparison, Bonferroni adjustment was performed to evaluate the variation in CCT values against time in the same group and to evaluate variation in the difference in CCT (dCCT) from baseline (10 min after cannulation) against time, which was compared with dCCT at the same time point between groups.

RESULTS

Tables 1 and 2 show the results of one-way repeated measures ANOVA following pairwise comparison with Bonferroni adjustment of the CCT and dCCT, respectively. There was a significant difference in the effect of time on CCT (P<0.001) and dCCT (P<0.001) between groups. There was no significant difference in the effect of time on CCT in group C15 (P=0.729). The CCT in group C15 remained constant over the course of 70 min. However, there was a significant difference in the effect of time on CCT in group T (P<0.001). The CCT in group T initially decreased until 40 min and then began to increase. The CCT in group T was unchanged at 20 min compared with at 10 min. However, the CCTs at 30 (P=0.006) and 40 min (P=0.028) were significantly thinner than that at 10 min in group T. Furthermore, the CCTs at 50, 60 and 70 min were significantly thicker than those at 30 and 40 min in group T. There was a significant difference in the effect of time on CCT in group C30 (P=0.032). The CCT in group C30 decreased until 30 min and was then maintained. The CCT in group C30 was unchanged at 20 min compared with at 10 min. However, the CCTs at 30 (P=0.003) and 40 min (P=0.045) were significantly thinner than that at 10 min in group C30. There was a significant difference in the effect of time on CCT in group C45 (P<0.001). The CCT in group C45 was unchanged at 40 min compared with at 10 min and then showed a significant increase. The CCTs in group C45 at 20, 30 and 40 min were significantly thinner than those at 50, 60 and 70 min. There was a significant difference in the effect of time on CCT in group C60 (P<0.001) and group C75 (P<0.001). The CCT in group C60 was unchanged at 20 min compared with at 10 min and then showed a significant increase, except at 50 min to 60 min. The CCT in group C75 showed a steady significant increase after cannulation, except at 30 min to 40 min.
Table 1.

Central corneal thickness (CCT; microns) changes according to experimental adjustment of IOP

The timeafter cannulation (min)IOP of T group(mmHg)TC15*C30*C45*C60*C75*
1010519.8 ± 15.0513.9 ± 15.0508.1 ± 23.3487.7 ± 23.3513.3 ± 23.3480.2 ± 23.3
2020516.3 ± 15.1513.6 ± 15.1500.4 ± 23.1479.5 ± 23.1519.4 ± 23.1490.8 ± 23.1a)
3030512.2 ± 14.9a)514.2 ± 14.9494.2 ± 22.9a)482.5 ± 22.9531.5 ± 22.9a),b)504.7 ± 22.9a),b)
4040511.7 ± 15.1a)513.9 ± 15.1494.7 ± 23.0a)486.8 ± 23.0544.9 ± 23.0a),b),c)512.2 ± 23.0a),b)
5050519.1 ± 15.6c),d)513.6 ± 15.6494.3 ± 23.4498.5 ± 23.4b),c),d)557.3 ± 23.4a),b),c),d)524.1 ± 23.4a),b),c),d)
6060529.8 ± 15.4b),c),d),e)512.3 ± 15.4494.3 ± 23.4504.1 ± 23.4b),c),d)561.9 ± 23.4a),b),c),d)532.7 ± 23.4a),b),c),d),e)
7070535.3 ± 15.2a),b),c),d),e)515.3 ± 15.2495.3 ± 23.4513.3 ± 23.4a),b),c),d),e)581.1 ± 23.4a),b),c),d),e),f)545.5 ± 23.4a),b),c),d),e),f)

Data for CCT are expressed as the mean ± SE (standard error). a) Values in the same column with this superscript are significantly different (P<0.05) compared with the CCT at 10 min. b) Values in the same column with this superscript are significantly different (P<0.05) compared with the CCT at 20 min from 30 min onward. c) Values in the same column with this superscript are significantly different (P<0.05) compared with the CCT at 30 min from 40 min onward. d) Values in the same column with this superscript are significantly different (P<0.05) compared with the CCT at 40 min from 50 min onward. e) Values in the same column with this superscript are significantly different (P<0.05) compared with the CCT at 50 min from 60 min onward. f) Values in the same column with this superscript are significantly different (P<0.05) in CCT at 70 min compared with that at 60 min. *The IOPs of groups C15, C30, C45, C60 and C 75 were maintained at 15, 30, 45, 60 and 75 mmHg, respectively, during the experiment.

Data for CCT are expressed as the mean ± SE (standard error). a) Values in the same column with this superscript are significantly different (P<0.05) compared with the CCT at 10 min. b) Values in the same column with this superscript are significantly different (P<0.05) compared with the CCT at 20 min from 30 min onward. c) Values in the same column with this superscript are significantly different (P<0.05) compared with the CCT at 30 min from 40 min onward. d) Values in the same column with this superscript are significantly different (P<0.05) compared with the CCT at 40 min from 50 min onward. e) Values in the same column with this superscript are significantly different (P<0.05) compared with the CCT at 50 min from 60 min onward. f) Values in the same column with this superscript are significantly different (P<0.05) in CCT at 70 min compared with that at 60 min. *The IOPs of groups C15, C30, C45, C60 and C 75 were maintained at 15, 30, 45, 60 and 75 mmHg, respectively, during the experiment. There was a statistically significant difference in dCCT between groups C15 and C70 at 20 min (P=0.040). The dCCTs in groups C60 (P=0.031) and C75 (P=0.001) were significantly thicker than that in group C30 at 20 min. The dCCTs in groups C60 and C75 were also significantly thicker than those in groups T, C15, C30 and C45 at 30, 40, 50, 60 and 70 min. There was a statistically significant difference in dCCT between groups C15 and C30 at 30 min (P=0.010). There were also statistically significant differences in dCCT between groups T and C30 at 60 (P=0.012) and 70 min (P=0.016). There were statistically significant differences in dCCT between groups C30 and C45 at 50 (P=0.024), 60 (P=0.008) and 70 min (P=0.005; Table 2).
Table 2.

Difference in CCT (dCCT; microns) from baseline value according to experimental adjustment of IOP

The timeafter cannulation (min)IOP of T group(mmHg)TC15*C30*C45*C60*C75*
10(baseline)10000000
2020–3.5 ± 1.7f)–0.3 ± 1.7f)–7.7 ± 3.0e),f)–8.2 ± 3.0e),f)6.1 ± 3.0c),d)10.6 ± 3.0a),b),c),d)
3030–7.6 ± 1.9e),f)0.3 ± 1.9c),e),f)–13.9 ± 3.4b),e),f)–5.1 ± 3.4e),f)18.1 ± 3.4a),b),c),d)24.4 ± 3.4a),b),c),d)
4040–8.1 ± 2.4e),f)0.0 ± 2.4e),f)–13.4 ± 4.1e),f)–0.9 ± 4.1e),f)31.5 ± 4.1a),b),c),d)32.0 ± 4.1a),b),c),d)
5050–0.7 ± 3.0e),f)–0.3 ± 3.0e),f)–13.8 ± 5.1d),e),f)10.8 ± 5.2c),e),f)44.0 ± 5.2a),b),c),d)43.8 ± 5.2a),b),c),d)
606010.0 ± 3.3c),e),f)–1.5 ± 3.3e),f)–13.8 ± 5.7a),d),e),f)16.4 ± 5.7c),e),f)48.6 ± 5.7a),b),c),d)52.5 ± 5.7a),b),c),d)
707015.5 ± 4.0e),f)1.4 ± 4.0e),f)–12.9 ± 7.0a),d),e),f)25.6 ± 7.0c),e),f)67.7 ± 7.0a),b),c),d)65.2 ± 7.0a),b),c),d)

Data for dCCT are expressed as the mean ± SE (standard error). a) Values in the same row with this superscript are significantly different (P<0.05) compared with the group T. b) Values in the same row with this superscript are significantly different (P<0.05) compared with the group C15. c) Values in the same row with this superscript are significantly different (P<0.05) compared with the group C30. d) Values in the same row with this superscript are significantly different (P<0.05) compared with the group C45. e) Values in the same row with this superscript are significantly different (P<0.05) compared with the group C60. f) Values in the same row with this superscript are significantly different (P<0.05) compared with the group C75. *The IOPs of groups C15, C30, C45, C60 and C75 were maintained at 15, 30, 45, 60 and 75 mmHg, respectively, during the experiment.

Data for dCCT are expressed as the mean ± SE (standard error). a) Values in the same row with this superscript are significantly different (P<0.05) compared with the group T. b) Values in the same row with this superscript are significantly different (P<0.05) compared with the group C15. c) Values in the same row with this superscript are significantly different (P<0.05) compared with the group C30. d) Values in the same row with this superscript are significantly different (P<0.05) compared with the group C45. e) Values in the same row with this superscript are significantly different (P<0.05) compared with the group C60. f) Values in the same row with this superscript are significantly different (P<0.05) compared with the group C75. *The IOPs of groups C15, C30, C45, C60 and C75 were maintained at 15, 30, 45, 60 and 75 mmHg, respectively, during the experiment.

DISCUSSION

Although IOP can be a factor in CCT variation, there are few experimental studies that have investigated this relationship in either animals or humans [12, 24]. The current study showed that CCT varied according to different experimental adjustments of IOP. The CCT showed two core changes according to increased IOP. CCT initially decreased in response to increased IOP in groups T and C30. Also, a significant decrease in dCCT in group C30 compared with C15 was identified at 30 min. However, in groups T, C45, C60 and C75, it appears that the CCT ultimately increased after passing the critical pressure. Comparing groups C45, C60 and C75, there is evidence to say the duration and degree of increase in IOP was a factor contributing to the increase in CCT. In previous human studies, there was no obvious change in CCT when the IOP was increased by approximately 10 mmHg, although the duration of the increase in IOP was only 5 min [12]. A similar result was found in the current study with no statistical difference in CCT values between 10 and 20 mmHg in group T. However, a significant difference in CCT was shown in this group when the IOP was elevated above 30 mmHg, which is adjacent to the upper limit of the physiologically normal IOP [6]. Olsen [18] suggested that IOP showed a dual effect on corneal thickness according to corneal endothelium conditions in human patients with acute glaucoma. First, CCT decreases in response to an increase in IOP in the intact corneal endothelium, and second, it increases in the acutely damaged corneal endothelium. Ehlers et al. documented that CCT in eyes with a low IOP was thicker than that in contralateral normal eyes in human patients with retinal detachment [4]. The results of this study also indicated a similar conclusion. Initially, CCT gradually decreased with an increase in IOP until 40 min (40 mmHg) in group T. The CCTs at 30 and 40 min were significantly different from that at 10 min in group T. However, CCT was increased from 50 min (50 mmHg) to 70 min (70 mmHg) in group T. The CCTs at 30 and 40 min were significantly different from those at 50, 60 and 70 min in group T. The initial decrease in CCT according to elevated IOP is associated with microsturctural changes in the corneal anterior stroma. The anterior stroma is more resistant to corneal hydration, and the transverse collagen lamellae of the anterior stroma are short [3, 23]. An initial decrease in CCT can be caused by immediate loss of anterior stromal interlamellar gaps with increasing IOP in rabbits [23]. Abnormal thickening of the cornea presents as corneal edema, which can appear when the IOP is above 40 mmHg in human glaucoma patients [25]. In this study, CCT increased after IOP passed the lowest point of 40 mmHg (40 min) in group T, and significant differences in CCT were also observed between CCTs in group C45 at 20 min and 50 min. Therefore, it can be proposed that corneal endothelial decompensation was initiated at an IOP of 40 to 45 mmHg in normal canine eyes. The duration and degree of increased IOP should also be considered when assessing the initiation of thickening of the CCT. In group C45, there was a significant increase in CCT beginning at 50 min. Also, there were significant increases in CCT beginning at 30 min and 20 min in groups C60 and C75, respectively. Furthermore, there were significant increases in dCCT compared with group C15 beginning at 30 min and 20 min in groups C60 and C75, respectively. Therefore, the initiation of thickening of the CCT was influenced by the duration and degree of IOP increase. A high degree of IOP may cause thickening of the CCT to occur rapidly. In humans, a thin CCT was considered a risk factor for glaucoma in the Ocular Hypertension Treatment Study [8]. This relationship might be partially explained when considering the effect of CCT on IOP measurement [15]. Although the effect of CCT was different with each type of tonometer used, the measured IOP can be lower than the real IOP in both humans and dogs with a thin CCT [2, 10, 19]. Therefore, glaucoma patients with a thin CCT can be measured as having a normal IOP when using tonometry. CCT is also correlated with the development of glaucomatous visual field loss in humans [9, 13, 16]. Although this study was performed over a short duration (70 min), the results support that thin CCT can be a promising source for diagnosis and monitoring of glaucoma in dogs. Thinning of the cornea was not correlated with tonometer readings in this study, because manometric values were used. Although the reductions in CCT were quite small, there were significant differences in CCT between 10 min and 30 min in groups T and C30. CCT itself changed with an increased IOP, exhibiting an initial decrease and then a subsequent increase. In this study, changes in CCT according to experimental adjustment of IOP were documented, and the possibility of using CCT as a diagnostic and monitoring factor for canine glaucoma was suggested. This study provides basic data to enable further investigation of the relationship between CCT and IOP in dogs.
  24 in total

1.  The architecture of the corneal stroma.

Authors:  A J Bron
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Corneal indentation during ultrasonic pachometry.

Authors:  O D Solomon
Journal:  Cornea       Date:  1999-03       Impact factor: 2.651

3.  Effect of corneal thickness on intraocular pressure measurements with the pneumotonometer, Goldmann applanation tonometer, and Tono-Pen.

Authors:  Archana Bhan; Andrew C Browning; Sunil Shah; Robin Hamilton; Dinesh Dave; Harminder S Dua
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

4.  CORNEAL EDEMA AND INTRAOCULAR PRESSURE. 1. ANIMAL EXPERIMENTS.

Authors:  J YTTEBORG; C DOHLMAN
Journal:  Arch Ophthalmol       Date:  1965-09

5.  The role of the epithelium in control of corneal hydration.

Authors:  M V Riley
Journal:  Exp Eye Res       Date:  1971-07       Impact factor: 3.467

6.  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

Authors:  Mae O Gordon; Julia A Beiser; James D Brandt; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Michael A Kass
Journal:  Arch Ophthalmol       Date:  2002-06

7.  Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy.

Authors:  Felipe A Medeiros; Pamela A Sample; Linda M Zangwill; Christopher Bowd; Makoto Aihara; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2003-11       Impact factor: 5.258

Review 8.  Intraocular pressure and central corneal thickness.

Authors:  Gianluca Manni; Francesco Oddone; Vincenzo Parisi; Adriana Tosto; Marco Centofanti
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

9.  Relationship between central corneal thickness and visual field defect in open-angle glaucoma.

Authors:  Wenzhong Lin; Yumiko Aoyama; Kazuhide Kawase; Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2009-10-22       Impact factor: 2.447

10.  Effect of inflammation on the corneal endothelial pump and barrier.

Authors:  J M Macdonald; D H Geroski; H F Edelhauser
Journal:  Curr Eye Res       Date:  1987-09       Impact factor: 2.424

View more
  8 in total

1.  Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation.

Authors:  Mojdeh Abbasi; Vivek K Gupta; Nitin Chitranshi; Veer B Gupta; Mehdi Mirzaei; Yogita Dheer; Linda Garthwaite; Thiri Zaw; Robert G Parton; Yuyi You; Stuart L Graham
Journal:  Mol Neurobiol       Date:  2020-06-23       Impact factor: 5.590

2.  Real-time intraocular pressure measurement during phacoemulsification in dogs ex vivo.

Authors:  Seonmi Kang; Sangwan Park; Hyunwoo Noh; Jiyoon Kwak; Kangmoon Seo
Journal:  J Vet Med Sci       Date:  2015-02-16       Impact factor: 1.267

3.  Correlation of IOP with Corneal Acoustic Impedance in Porcine Eye Model.

Authors:  Jun Zhang; Yi Zhang; Yang Li; Ruimin Chen; K Kirk Shung; Grace Richter; Qifa Zhou
Journal:  Biomed Res Int       Date:  2017-05-31       Impact factor: 3.411

4.  High myopia induced by form deprivation is associated with altered corneal biomechanical properties in chicks.

Authors:  Byung Soo Kang; Li-Ke Wang; Yong-Ping Zheng; Jeremy A Guggenheim; William K Stell; Chea-Su Kee
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

5.  Optimization of orbital retraction during endoscopic transorbital approach via quantitative measurement of the intraocular pressure - [SevEN 006].

Authors:  Woohyun Kim; Ju Hyung Moon; Eui Hyun Kim; Chang-Ki Hong; Jisang Han; Je Beom Hong
Journal:  BMC Ophthalmol       Date:  2021-02-08       Impact factor: 2.209

6.  Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner.

Authors:  Mojdeh Abbasi; Vivek K Gupta; Nitin Chitranshi; Veer Gupta; Reza Ranjbaran; Rashi Rajput; Kanishka Pushpitha; Devaraj Kb; Yuyi You; Ghasem Hosseini Salekdeh; Robert G Parton; Mehdi Mirzaei; Stuart L Graham
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

7.  The influence of the tonometer position on canine intraocular pressure measurements using the Tonovet® rebound tonometer.

Authors:  Juliana Kravetz de Oliveira; Fabiano Montiani-Ferreira; David L Williams
Journal:  Open Vet J       Date:  2018-03-09

8.  Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients : Corneal endothelium after dexamethasone implant injection.

Authors:  Hatice Ayhan Güler; Nurgül Örnek; Kemal Örnek; Nesrin Büyüktortop Gökçınar; Tevfik Oğurel; Mehmet Erhan Yumuşak; Zafer Onaran
Journal:  BMC Ophthalmol       Date:  2018-09-04       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.